别名 PCLBCL、Primary Cutaneous Diffuse Large B-Cell Lymphoma、Primary cutaneous diffuse large cell B-cell lymphoma + [3] |
简介 A diffuse large B-cell lymphoma that arises from the skin. This category includes primary cutaneous diffuse large B-cell lymphoma, leg type, and primary cutaneous diffuse large B-cell lymphoma, other, which includes primary cutaneous intravascular large B-cell lymphoma and primary cutaneous T-cell/histiocyte-rich large B-cell lymphoma. |
靶点 |
作用机制 CD19抑制剂 |
在研机构 |
原研机构 |
非在研适应症 |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
靶点 |
作用机制 MALT1抑制剂 |
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2023-11-15 |
开始日期2023-04-10 |
申办/合作机构 |
开始日期2019-02-19 |